Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017.

NCT00799747 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: AZD4017
DRUG: Placebo

Sponsor

AstraZeneca